This study is a test of the safety and effectiveness of two drugs, one for diabetes and one
for hypertension, in keeping patients with high lab values of glucose from progressing to
frank diabetes and developing cardiovascular complications. People in this study cannot
have frank diabetes but are considered "borderline" based on blood tests. People in the
study take none, one or both of the drugs and do not know which one(s) they are taking.
Minimum age: 50 Years.
Maximum age: N/A.
Gender(s): Both.
Investigative Site, Argentina
Investigative Site, Australia
Investigative Sites, Austria
Investigative Site, Belgium
Investigative Site, Brazil
Investigative Site, Canada
Investigative Site, Chile
Investigative Site, China
Investigative Site, Colombia
Investigative Site, Czech Republic
Investigative Site, Denmark
Investigative Site, Ecuador
Investigative Site, Finland
Investigative Site, France
Investigative Site, Germany
Investigative Site, Greece
Investigative Site, Guatemala
Investigative Site, Hong Kong
Investigative Site, Hungary
Investigative Site, Italy
Investigative Site, Malaysia
Investigative Site, Mexico
Investigative Site, Netherlands
Investigative Site, Norway
Investigative Site, Peru
Investigative Site, Poland
Investigative Site, Russian Federation
Investigative Site, Singapore
Investigative Site, Slovakia
Investigative Site, South Africa
Investigative Site, Spain
Investigative Site, Sweden
Investigative Site, Switzerland
Investigative Site, Taiwan
Investigative Site, Turkey
Investigative Site, United Kingdom
Investigative Site, Uruguay
Investigative Site, New Jersey, United States